Skip to main content
. 2019 Jan 31;7(2):121–126. doi: 10.1093/gastro/goz001

Figure 1.

Figure 1.

Vedolizumab outcomes. mPDAI, modified pouch disease activity index; EIM, extra-intestinal manifestations.